Anavex Life Sciences Corp (AVXL)

[McMagyar]

High dosage has been the equalizer
of outcomes . We don’t know the outcomes.. but the company has stated that high dosage has been the recurring theme for outcomes.

What other outcome could there be for high dosage other than success?

If failure was the outcome of high dosage..
Than surely failure would have been the outcome of low dosage! Right??

So .. for high dosage 1/3 of phase 2b/3 trial we are at 100% success!

Surely some of the low dosage experienced higher than placebo results..

And we have 1 year OLE data all at high dosage for almost all participants..


This isn’t complicated stuff
But the thousand friendly cuts are just short sellers helping institutional buyers get cheap stock..

When the news hits institutional buyers will own 80% of float at $50 per share..

And people who destroy and slash our chances will have earned their silver coins